Page 40 - ARNM-2-3
P. 40

Advances in Radiotherapy
            & Nuclear Medicine                                                        Molecular imaging of lung cancer



               doi: 10.1016/j.jtho.2021.02.023                    doi: 10.7150/thno.79625
            9.   Tamura T, Kurishima K, Nakazawa K, et al. Specific organ   19.  Lusic  H,  Grinstaff  MW.  X-ray-computed  tomography
               metastases and survival in metastatic nonsmallcell lung   contrast agents. Chem Rev. 2013;113(3):1641-1666.
               cancer. Mol Clin Oncol. 2015;3(1):217-221.         doi: 10.1021/cr200358s
               doi: 10.3892/mco.2014.410                       20.  Mahajan S, Barker CA, Singh B, Pandit-Taskar N. Clinical
            10.  The National Lung Screening Trial Research Team. Results   value of 18F-FDG-PET/CT in staging cutaneous squamous
               of initial low-dose computed tomographic screening for   cell carcinoma. Nucl Med Commun. 2019;40(7):744-751.
               lung cancer. N Engl J Med. 2013;368(21):1980-1991.     doi: 10.1097/MNM.0000000000001029
               doi: 10.1056/NEJMoa1209120                      21.  Loktev A, Lindner T, Mier W,  et al. A  tumor-imaging
            11.  de Koning HJ, van Der Aalst CM, de Jong PA, et al. Reduced   method targeting cancer-associated fibroblasts. J Nucl Med.
               lung-cancer mortality with volume CT screening in a   2018;59(9):1423-1429.
               randomized trial. N Engl J Med. 2020;382(6):503-513.     doi: 10.2967/jnumed.118.210435
               doi: 10.1056/NEJMoa1911793                      22.  Alwadani B, Dall’Angelo S, Fleming IN. Clinical value of
            12.  Han Y, Kim HJ, Kong KA,  et al. Diagnosis of small   3’-deoxy-3’-[(18)F]fluorothymidine-positron  emission
               pulmonary lesions by transbronchial lung biopsy with   tomography for diagnosis, staging and assessing therapy
               radial endobronchial ultrasound and virtual bronchoscopic   response in lung cancer. Insights Imaging. 2021;12(1):90.
               navigation  versus  CT-guided  transthoracic  needle  biopsy:      doi: 10.1186/s13244-021-01026-1
               A  systematic review and meta-analysis.  PLoS One.
               2018;13(1):e0191590.                            23.  Niemeijer  AN,  Leung  D,  Huisman  MC,  et al.  Whole
                                                                  body PD-1 and PD-L1 positron emission tomography in
               doi: 10.1371/journal.pone.0191590                  patients with non-small-cell lung cancer.  Nat Commun.
                                                                  2018;9(1):4664.
            13.  Tielemans B, Dekoster K, Verleden SE, et al. From mouse to
               man and back: Closing the correlation gap between imaging      doi: 10.1038/s41467-018-07131-y
               and histopathology for lung diseases.  Diagnostics  (Basel).
               2020;10(9):636.                                 24.  Kok IC, Hooiveld JS, van de Donk PP,  et al. (89)
                                                                  Zr-pembrolizumab imaging as a non-invasive approach to
               doi: 10.3390/diagnostics10090636                   assess clinical response to PD-1 blockade in cancer.  Ann
                                                                  Oncol. 2022;33(1):80-88.
            14.  Zaw Thin M, Moore C, Snoeks T, Kalber T, Downward J,
               Behrens A. Micro-CT acquisition and image processing      doi: 10.1016/j.annonc.2021.10.213
               to track and characterize pulmonary nodules in mice. Nat   25.  Franquet  E,  Park  H.  Molecular  imaging  in  oncology:
               Protoc. 2023;18(3):990-1015.
                                                                  Common PET/CT radiopharmaceuticals and applications.
               doi: 10.1038/s41596-022-00769-5                    Eur J Radiol Open. 2022;9:100455.
            15.  Brodersen J, Voss T, Martiny F, Siersma V, Barratt A, Heleno  B.      doi: 10.1016/j.ejro.2022.100455
               Overdiagnosis of lung cancer with low-dose computed   26.  Biederer J, Ohno Y, Hatabu H,  et al. Screening for lung
               tomography screening: Meta-analysis of the randomised   cancer: Does MRI have a role? Eur J Radiol. 2017;86:353-360.
               clinical trials. Breathe (Sheff). 2020;16(1):200013.
                                                                  doi: 10.1016/j.ejrad.2016.09.016
               doi: 10.1183/20734735.0013-2020
                                                               27.  Ohno Y, Koyama H, Yoshikawa T, et al. Standard-, reduced-,
            16.  Lancaster HL, Heuvelmans MA, Oudkerk M. Low‐dose   and no-dose  thin-section radiologic examinations:
               computed tomography lung cancer screening: Clinical   Comparison of capability for nodule detection and nodule
               evidence and implementation research.  J  Intern Med.   type assessment in patients suspected of having pulmonary
               2022;292(1):68-80.                                 nodules. Radiology. 2017;284(2):562-573.
               doi: 10.1111/joim.13480                            doi: 10.1148/radiol.2017161037
            17.  Lubbers MM, Kock M, Niezen A,  et  al. Iodixanol versus   28.  Burris NS, Johnson KM, Larson PE, et al. Detection of small
               iopromide at coronary CT angiography: Lumen opacification   pulmonary nodules with ultrashort echo time sequences in
               and effect on heart rhythm-the randomized isoCOR trial.   oncology patients by using a PET/MR system.  Radiology.
               Radiology. 2018;286(1):71-80.                      2016;278(1):239-246.
               doi: 10.1148/radiol.2017162779                     doi: 10.1148/radiol.2015150489
            18.  Jiang Z, Zhang M, Li P, Wang Y, Fu Q. Nanomaterial-based   29.  Sanchez F, Tyrrell PN, Cheung P, et al. Detection of solid and
               CT contrast agents and their applications in image-guided   subsolid pulmonary nodules with lung MRI: Performance of
               therapy. Theranostics. 2023;13(2):483-509.         UTE, T1 gradient-echo, and single-shot T2 fast spin echo.


            Volume 2 Issue 3 (2024)                         8                              doi: 10.36922/arnm.4173
   35   36   37   38   39   40   41   42   43   44   45